Venture capital firm based in Oxford, UK
Lightcast raises £19.9m to commercialise Envisia benchtop using light‑controlled droplet assays. Read more
Biofidelity secures $24M in funding to revolutionize cancer care with cutting-edge genomic technology, propelling its mission to enhance and prolong the lives of cancer patients worldwide. Read more
With a fresh £4.6 million investment, Wayland Additive is revolutionizing the 3D printing game, unleashing cutting-edge technology that could redefine precision manufacturing across industries from aerospace to medicine. Read more
| Healthtech | 66.7% |
| Biotech | 33.3% |